Last reviewed · How we verify
NCT05717465
Communicating Risks: Consent for Lumbar Puncture
NA trial testing Anatomy diagrams in Informed Consent, Health Literacy, Risk, Spinal Puncture, Neurosurgery in 52 participants. Completed in 26 May 2022.
26 May 2022
Quick facts
| Lead sponsor | University College London Hospitals |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 52 |
| Start date | 27 March 2022 |
| Primary completion | 26 May 2022 |
| Estimated completion | 26 May 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Anatomy diagrams
- Standard informed consent
Conditions studied
- Informed Consent, Health Literacy, Risk, Spinal Puncture, Neurosurgery — all drugs for Informed Consent, Health Literacy, Risk, Spinal Puncture, Neurosurgery →
Sponsor
University College London Hospitals
Who can join
18 and older, any sex, with Informed Consent, Health Literacy, Risk, Spinal Puncture, Neurosurgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized control trial is to compare the effect of visual aids on the recall of probabilistic risks in healthy participants. The main questions it aims to answer are: * Will participants consented using a consent process incorporating visual aids recall the consent process better? * Will participants consented with a consent process incorporating visual aids have higher acceptability if a hypothetical, simulated complication were to occur? * Is this method of consent (visual aids) usable, appropriate and acceptable? Participants will be required to watch a brief video containing information on how a lumbar puncture is performed as well as the associated risks. * Participants in the intervention group will receive information in the form of various visual aids (e.g. anatomical diagrams, paling palettes and paling perspective scales). The audio narration and information provided in both groups is identical. * Participants will be tested on their knowledge of the procedure * Participants will be asked to rate their response to a series of procedure specific statements and statements from other validated scales. Researchers will compare the control and intervention group to see if there is improvement in the recall of information and which consent process is more acceptable, appropriate and usable.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improving risk communication: a proof-of-concept randomised control trial assessing the impact of visual aids for neurosurgical consent
Chatzopoulou D, Jalal A, Stoyanov D, Marcus H, et al · · 2024
Verify or expand the search:
- PubMed search for NCT05717465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University College London Hospitals trials
Trials by the same sponsor.
- NCT07206394 — Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome. · NA · recruiting
- NCT05725174 — Volatile Non-Invasive Biomarkers of Epileptic Seizures · recruiting
- NCT05362448 — Neurophysiologic Assessment of ET Patients Treated by Vim DBS · NA · unknown
- NCT05460156 — The Bridges Self-management Programme for People With Neuromuscular Diseases · NA · completed
- NCT04661059 — Study of Late-foetal Human Organ Development · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05717465 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College London Hospitals
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05717465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing